lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Seroprevalence of Pertussis in Chinese Population During 2010-2022: A Systematic Review and Meta-Analysis

25 Pages Posted: 29 Dec 2023

See all articles by Yao Zhu

Yao Zhu

Zhejiang Provincial Center for Disease Control and Prevention

Wanting Zhang

Zhejiang University - Department of Public Health

Jie Hu

Jiaxing Municipal Center for Disease Control and Prevention

Shuying Luo

Yiwu District Center for Disease Control and Prevention

Yang Zhou

Zhejiang Provincial Center for Disease Control and Prevention

Xuewen Tang

Zhejiang Provincial Center for Disease Control and Prevention

Rui Yan

Zhejiang Provincial Center for Disease Control and Prevention

Xuan Deng

Zhejiang Provincial Center for Disease Control and Prevention

Ying Su

Zhejiang Chinese Medical University

Hanqing He

Zhejiang Provincial Center for Disease Control and Prevention

More...

Abstract

Background: Pertussis is a vaccine-preventable infectious disease, however, data on pertussis antibody levels in a nationwide population are still limited in China. We aimed to pool seropositive rate of antibody against pertussis toxin (PT-IgG) among Chinese population.

Methods: We systematically searched PubMed, Web of Science, Embase, and China National Knowledge Infrastructure Database for studies published between 1 January 2010 and 30 June 2023. The studies reporting seroprevalence on PT-IgG among healthy Chinese population are included. Pooled estimates were obtained using random-effect meta-analyses. The age-specific estimates in different years were used meta-regression.

Findings: Thirty-nine studies involving 47 778 subjects reporting the seropositive rates of anti-PT IgG were included in the meta-analysis. The pooled seropositive rate in the whole population was 7.06% (95% CI, 5.50%-9.07%). In subgroup meta-analyses, the estimates were 8.71%, 12.50%, 8.15%, 8.96%, 8.90% ,6.36% and 8.96% for people y aged <1, 1-2, 3-4, 5-9, 10-19, 20-39, and ≥40 years, respectively. The highest estimate was 11.89% for subjects in East China, but the lowest estimate was 6.36% for those in Southwestern China. A trend of decreasing seropositive rate of anti-PT IgG was observed during the past eight years, with a relative decreasing rate of 56.82% to 58.50% from 2012 to 2020. In 2020, the seropositive rate ranged from 7.22% (95% CI, 4.62%-11.11%) among children younger than 1 year old to 5.99% (95% CI, 3.94%-9.02%) among adults aged 40 years and older.

Interpretation: This meta-analysis showed a low seropositive rate of anti-PT IgG in the Chinese population, especially in school-age children and young adult, highlighting the urgent need for great efforts to optimize the immunization strategy.

Funding: This work was supported by the Zhejiang Provincial Medical and Health Science and Technology Project (grant number 2024KY885).

Declaration of Interest: The authors declare no conflicts of interest.

Keywords: Pertussis, Antibodies, Pertussis toxin, China, Meta-analysis

Suggested Citation

Zhu, Yao and Zhang, Wanting and Hu, Jie and Luo, Shuying and Zhou, Yang and Tang, Xuewen and Yan, Rui and Deng, Xuan and Su, Ying and He, Hanqing, Seroprevalence of Pertussis in Chinese Population During 2010-2022: A Systematic Review and Meta-Analysis. Available at SSRN: https://ssrn.com/abstract=4677011 or http://dx.doi.org/10.2139/ssrn.4677011

Yao Zhu

Zhejiang Provincial Center for Disease Control and Prevention ( email )

Binjiang
Hangzhou, 310051
China

Wanting Zhang

Zhejiang University - Department of Public Health ( email )

Jie Hu

Jiaxing Municipal Center for Disease Control and Prevention ( email )

Shuying Luo

Yiwu District Center for Disease Control and Prevention ( email )

Yang Zhou

Zhejiang Provincial Center for Disease Control and Prevention ( email )

Binjiang
Hangzhou, 310051
China

Xuewen Tang

Zhejiang Provincial Center for Disease Control and Prevention ( email )

Rui Yan

Zhejiang Provincial Center for Disease Control and Prevention ( email )

Binjiang
Hangzhou, 310051
China

Xuan Deng

Zhejiang Provincial Center for Disease Control and Prevention ( email )

Binjiang
Hangzhou, Zhejiang 310051
China

Ying Su

Zhejiang Chinese Medical University ( email )

Hangzhou
China

Hanqing He (Contact Author)

Zhejiang Provincial Center for Disease Control and Prevention ( email )

Binjiang
Hangzhou, 310051
China